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BSTRACT
 
Background and Methods
 
The characteristics and
frequency of clinical problems with the performance
of euthanasia and physician-assisted suicide are un-
certain. We analyzed data from two studies of eutha-
nasia and physician-assisted suicide in the Nether-
lands (one conducted in 1990 and 1991 and the other
in 1995 and 1996), with a total of 649 cases. We cate-
gorized clinical problems as technical problems, such
as difficulty inserting an intravenous line; complica-
tions, such as myoclonus or vomiting; or problems
with completion, such as a longer-than-expected in-
terval between the administration of medications and
death.
 
Results
 
In 114 cases, the physician’s intention was
to provide assistance with suicide, and in 535, the in-
tention was to perform euthanasia. Problems of any
type were more frequent in cases of assisted suicide
than in cases of euthanasia. Complications occurred
in 7 percent of cases of assisted suicide, and prob-
lems with completion (a longer-than-expected time
to death, failure to induce coma, or induction of coma
followed by awakening of the patient) occurred in 16
percent of the cases; complications and problems
with completion occurred in 3 percent and 6 percent
of cases of euthanasia, respectively. The physician
decided to administer a lethal medication in 21 of the
cases of assisted suicide (18 percent), which thus be-
came cases of euthanasia. The reasons for this deci-
sion included problems with completion (in 12 cas-
es) and the inability of the patient to take all the
medications (in 5).
 
Conclusions
 
There may be clinical problems with
the performance of euthanasia and physician-assist-
ed suicide. In the Netherlands, physicians who intend
to provide assistance with suicide sometimes end
up administering a lethal medication themselves be-
cause of the patient’s inability to take the medica-
tion or because of problems with the completion of
physician-assisted suicide. (N Engl J Med 2000;342:
551-6.)
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LTHOUGH euthanasia and physician-
assisted suicide are illegal in most coun-
tries, they are performed in several parts
of the world.
 
1-9
 
 Oregon has made physi-
cian-assisted suicide legal under specified conditions.
 
10
 
In the Netherlands, a physician who performs eutha-
nasia or provides assistance with suicide will not be
prosecuted if the act has been carried out under strict
conditions, which have been formulated by the courts
and the medical profession.
 
11
 
 One of these condi-
tions is that euthanasia or assistance with suicide must
be carried out in a professionally responsible way. In
1987, the Royal Dutch Association of Pharmacy is-
sued guidelines on the use and preparation of drugs
for euthanasia. The guidelines were revised on the
basis of doctors’ experiences in 1994 and 1998.
 
12,13
 
The incidence of physician-assisted suicide and eu-
thanasia and attitudes toward these practices have
been studied extensively, but the few reports on the
clinical aspects of these practices are based on limit-
ed data or small numbers of cases.
 
14-18
 
 We performed
a study to determine whether there are problems with
the clinical aspects of euthanasia and physician-assist-
ed suicide as reported by the physicians involved, in-
cluding complications and problems with completion,
such as a prolonged interval between the administra-
tion of medications and the patient’s death.
 
METHODS
 
Study Design
 
In 1990 and 1991 and in 1995 and 1996, we performed two
studies of euthanasia, physician-assisted suicide, and other medi-
cal practices involving the end of life in the Netherlands. Detailed
information about the design of these studies has been reported
elsewhere.
 
1,19,20
 
 In three parts of the studies, detailed information
on the clinical aspects of euthanasia and physician-assisted suicide
was collected.
In 1990 and 1991, we interviewed a stratified random sample
of 405 physicians that included 152 general practitioners, 50
A
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nursing home physicians, and 203 physicians in the specialties of
cardiology, surgery, internal medicine, pulmonology, and neurol-
ogy. Nine percent of eligible physicians declined to take part in
the study. The interviews were based on an extensive question-
naire and lasted an average of 2.5 hours. Respondents were asked
whether they had ever performed euthanasia or provided assist-
ance with suicide. If the answer was yes, more detailed questions
were asked about the most recent case. Some of the questions were
about technical problems, complications, and the length of the
interval between the administration of medications and death.
In 1995 and 1996, we replicated the earlier interview study. We
interviewed a randomized stratified sample of 405 physicians, in-
cluding 124 general practitioners, 74 nursing home physicians,
and 207 physicians in the specialties noted above. Eleven percent of
eligible physicians declined to take part in the study. The question-
naire was virtually identical to the one used in the 1990–1991 study.
In 1995 and 1996, we also interviewed a random sample of
147 physicians who had reported a case of physician-assisted sui-
cide or euthanasia for judicial review by the public prosecutor be-
tween August 1, 1994, and February 1, 1995. Ten percent of el-
igible physicians declined to be interviewed. We asked the physicians
questions about the reported case and the most recent unreport-
ed case (if any). In addition, we interviewed 63 of 64 eligible phy-
sicians who had been involved in cases of physician-assisted suicide
or euthanasia discussed in the Assembly of Prosecutors General
between January 1, 1991, and July 1, 1995. One physician declined
to be interviewed. The questionnaire was similar to the one used
in the 1990–1991 and 1995–1996 interview studies.
The protocol for the studies was reviewed and approved by a
special committee of the Dutch Ministry of Health, Welfare, and
Sports and the Dutch Ministry of Justice. It was also approved by
the Royal Dutch Medical Association.
To obtain data from a sufficiently large number of cases, we
combined all cases of euthanasia and physician-assisted suicide for
which information on clinical problems was available. There were
649 such cases: 185 from the 1990–1991 interview study, 194
from the 1995–1996 interview study, and 270 from the 1995–
1996 reported-cases study. These cases were divided into two
groups according to whether the physician’s intention had been
to provide assistance with suicide or to perform euthanasia. Cases
in which all the lethal drugs were administered by the patient
were assigned to the assisted-suicide group, as were cases in which
the last drug was administered by another person, although the
intention had been that the patient would administer all the drugs.
Cases in which someone other than the patient administered at
least one of the lethal drugs at the patient’s explicit request were
assigned to the euthanasia group.
The data we used did not represent a random sample of cases,
since we combined cases from different (stratified) samples and
asked physicians about only the most recent case. We performed
three analyses to assess the degree to which our data were repre-
sentative of all cases of euthanasia or assisted suicide in the Neth-
erlands. We compared the prevalence of technical problems, com-
plications, and problems with completion between samples and
according to the type of practice. We also analyzed the probabil-
ity of a problem according to the number of cases of physician-
assisted suicide or euthanasia that physicians had been involved in
during the two years before the interview. Finally, we repeated all
our analyses with only the data from the 1990–1991 interview
study and the 1995–1996 interview study, which were both based
on representative samples. The prevalence of technical problems,
complications, and problems with completion was virtually iden-
tical for all samples and for all types of practice, and the likelihood
of a problem was not related to the physician’s prior experience
with physician-assisted suicide or euthanasia. Therefore, we report
the results for the overall samples.
 
*Data were missing for one case in the 1995–1996 interview study and three cases in the reported-
cases study.
†Data were missing for three cases in the 1995–1996 interview study and three cases in the re-
ported-cases study.
‡Data were missing for four cases in the 1995–1996 interview study and three cases in the report-
ed-cases study.
§Data were missing for 4 cases in the 1995–1996 interview study and 12 cases in the reported-
cases study. Because of rounding, percentages do not all total 100.
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Patients
Men (%)* 51 59 54 55
Age (yr)†
Mean ±SD 62.3±14.4 62.6±13.8 65.9±14.9 63.9±14.5
Range 23–91 25–91 21–96 21–96
Diagnosis of cancer (%)‡ 78 82 68 75
Type of physician (%)
General practitioner 51 52 60 55
Specialist 46 40 34 39
Nursing home physician 3 8 6 6
Intended intervention (%)
Euthanasia 86 79 83 82
Physician-assisted suicide 14 21 17 18
Year of death (%)§
1987 or earlier 38 13 8 18
1988–1994 62 54 60 59
1995 or later — 34 33 23
Copyright © 2000 Massachusetts Medical Society. All rights reserved. 
Downloaded from www.nejm.org at ERASMUS UNIVERSITEIT MEDISCH BIBLIO on December 4, 2006 . 
 CLINICAL PROBLEMS WITH EUTHANASIA AND PHYSICIAN-ASSISTED SUICIDE IN THE NETHERLANDS
 
Volume 342 Number 8
 
·
 
553
 
We categorized clinical problems as technical problems, such as
difficulty inserting an intravenous line; complications, such as
spasm, myoclonus, nausea, or vomiting; and problems with com-
pletion, such as a longer-than-expected time to death or failure
to induce coma. If more than one type of medication was admin-
istered, the combination of drugs was classified according to the
drug with the greatest potential for causing death. Neuromuscu-
lar relaxants and potassium chloride were considered to have the
greatest lethal potential, followed by barbiturates, and then opi-
oids. Thus, for example, if a barbiturate and a neuromuscular re-
laxant had been administered, the medication was classified as a
neuromuscular relaxant, and if a barbiturate and an opioid had
been administered, the medication was classified as a barbiturate.
 
Statistical Analysis
 
The chi-square test was used for comparisons of categorical var-
iables. Two-sided P values of less than 0.05 were considered to in-
dicate statistical significance. All statistical analyses were performed
with SPSS software for Windows, version 7.5 (SPSS, Chicago).
 
RESULTS
 
The characteristics of the 649 cases of euthanasia
and assisted suicide are shown in Table 1. Fifty-five per-
cent of the patients were men, and the mean age was
63.9 years (range, 21 to 96). Seventy-five percent of
the patients had cancer. In 535 cases (82 percent),
the physician intended to perform euthanasia, and in
114 cases (18 percent), the intention was to provide
assistance with suicide.
 
Medications
 
In 367 of the 535 cases in which euthanasia was
intended (69 percent), a neuromuscular relaxant was
given (Table 2), in most cases after the administra-
tion of a barbiturate to induce coma. In 10 percent
of the euthanasia cases, a barbiturate was the only or
the most potent lethal drug administered; in 13 per-
cent, an opioid was the only or most potent lethal
drug administered. Potassium chloride was adminis-
tered in 2 percent of the euthanasia cases. In 485
cases of euthanasia (91 percent), a physician admin-
istered all or some of the medications. In 29 cases
(5 percent), a physician did not administer any of the
drugs: a nurse administered the drugs in 23 cases,
and another person (generally a family member) did
so in 6 cases. In 384 cases of euthanasia (72 per-
cent), the physician who completed the interview was
present continuously from the time the first drug
was administered until the patient’s death. In 10 cas-
es (2 percent), the respondent was not present at all;
instead, a colleague or a nurse administered the med-
ication.
In the group of 114 cases in which the intention
was to provide assistance with suicide, a barbiturate
was used in 81 cases (71 percent); in 9 cases (8 per-
cent), an opioid was used. In 14 percent of the cases,
a neuromuscular relaxant was administered after a bar-
biturate. In 85 cases (75 percent), the patient took the
drug (or drugs) without help. In 5 cases, the physi-
cian or a relative helped the patient take an oral drug;
in 19 other cases, the physician administered a sec-
ond or third drug parenterally because of complica-
tions or a perceived lack of effect of the first drug.
The physician who completed the interview was con-
tinuously present in 52 percent of cases of physician-
assisted suicide (P<0.001 for the comparison with
cases of euthanasia).
 
Clinical Problems
 
Table 3 shows the frequency of the clinical prob-
lems that occurred. Technical problems occurred in
35 cases (5 percent), complications in 24 cases (4 per-
cent), and problems with completion in 44 cases
(7 percent). In 10 cases, more than one type of prob-
lem occurred. Assisted suicide was more frequently
associated with each type of problem than was eu-
thanasia (P=0.03, P=0.03, and P=0.001, respective-
ly). General practitioners and nursing home physicians
were more likely than specialists to report technical
problems (P<0.001) and problems with completion
(P=0.04). Oral or rectal administration of medica-
tions was more likely than parenteral administration
to be associated with technical problems (P=0.003)
and problems with completion (P<0.001).
 
*For a description of how medications were classified, see the Methods
section.
†In seven cases, potassium chloride was also administered.
‡In eight cases, insulin was administered.
§Insulin was administered with a barbiturate in one case, orphenadrine
was administered in one case, and an unspecified combination of drugs was
administered in one case.
¶The patient may also have administered one or more drugs.
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no. of cases (%)
 
Medications*
Neuromuscular relaxant† 367 (69) 16 (14)
Potassium chloride 10 (2) —
Barbiturate 56 (10) 81 (71)
Opioid 70 (13) 9 (8)
Other drugs or drug combinations 19 (4)‡ 3 (3)§
Unknown 13 (2) 5 (4)
Person who administered drugs
Physician¶ 485 (91) 21 (18)
Nurse¶ 23 (4) —
Person other than physician or nurse¶ 6 (1) 3 (3)
Patient only — 85 (75)
Unknown 21 (4) 5 (4)
Presence or absence of physician
Continuously present 384 (72) 59 (52)
Present at intervals 61 (11) 18 (16)
Present after being called 39 (7) 20 (18)
Absent 10 (2) 11 (10)
Unknown 41 (8) 6 (5)
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Specific information about the reported problems
is provided in Table 4. The most common technical
problems were difficulty finding a vein in which to
inject the drug and difficulty administering an oral
medication. The most frequently mentioned compli-
cations were spasm or myoclonus and nausea or vom-
iting. The most common problems with completion
were a longer-than-expected interval between the
administration of medications and death and failure
to induce a comatose state. Table 5 shows the inter-
val between the administration of the medication (or
the first medication, if there was more than one) and
the patient’s death, as well as the physician’s assess-
ment of whether the interval was shorter than ex-
pected, longer than expected, or as expected.
 
Intervention of Physician in Cases of Assisted Suicide
 
In 21 of the cases in which the intention had been
to provide assistance with suicide, the physician ad-
ministered the lethal drug. In 12 of these cases, a
problem with completion was mentioned as the rea-
son for the physician’s intervention: the interval be-
tween the administration of medication and the oc-
currence of coma or death was too long (in 9 cases),
the patient did not become comatose after taking the
first drug (in 1), or the patient awoke from coma (in
2). In five other cases, the physician intervened be-
cause the patient had difficulty taking all the oral med-
ication; for example, one patient vomited after taking
the first medication, and one patient fell asleep before
taking all the medication. In four cases, no specific
reason for the physician’s intervention was given.
 
DISCUSSION
 
We found that there were sometimes clinical prob-
lems with the performance of physician-assisted sui-
cide and euthanasia. The problems reported by phy-
sicians frequently concerned a longer-than-expected
interval between the administration of the lethal drug
(or the first drug, if more than one was administered)
and the patient’s death. In general, problems were
more frequently reported in cases of assisted suicide
than in cases of euthanasia. The responsible physician
decided to administer the lethal medication in 21 of
114 cases in which the original intention had been
only to provide assistance with suicide. In most of
these cases, the patient did not die as soon as expect-
ed or awoke from coma, and the physician felt com-
pelled to administer a lethal injection because of the
anticipated failure of the assisted suicide. In some cas-
es, the physician administered a lethal injection be-
cause the patient had difficulty swallowing the oral
 
*In 10 cases, more than one type of problem occurred.
†Data were not available for eight cases.
‡Data were not available for six cases.
§Data were not available for 11 cases.
¶The P value is for the comparison of general practitioners and nursing home physicians with specialists.
¿The type of drug was not specified in 16 cases.
**In the 1990–1991 interview study, the route of administration was not determined; the 185 cases in that study were
therefore excluded from this analysis. In addition, data were not available for 21 cases in the other two studies; these cases
have also been excluded from the analysis.
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no./total no. (%) no./total no. (%) no./total no. (%)
 
Intended intervention 0.03 0.03 0.001
Euthanasia 535 24/529 (5) 16/532 (3) 28/528 (5)
Assisted suicide 114 11/112 (10) 8/111 (7) 16/110 (15)
Type of physician <0.001¶ 0.04¶
General practitioner 356 28/353 (8) 15/354 (4) 30/351 (9)
Specialist 256 4/253 (2) 6/253 (2) 11/252 (4)
Nursing home physician 37 3/35  (9) 3/36  (8) 3/35  (9)
Type of drug initially ad-
ministered¿
Barbiturate 320 21/317 (7) 11/317 (3) 19/315 (6)
Opioid 142 10/141 (7) 8/141 (6) 15/140 (11)
Other 171 3/169 (2) 5/171 (3) 10/169 (6)
Route of administration of
initial drug**
0.003 <0.001
Oral or rectal 116 14/115 (12) 8/113 (7) 15/113 (13)
Parenteral 327 14/325 (4) 12/326 (4) 11/324 (3)
All cases 649 35/641 (5) 24/643 (4) 44/638 (7)
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medication, vomited after swallowing it, or became
unconscious before swallowing all of it.
Two limitations of our study should be considered.
First, we included all cases of euthanasia and physi-
cian-assisted suicide for which we had clinical infor-
mation. These cases may not be representative of all
cases of euthanasia and assisted suicide in the Neth-
erlands. We performed several analyses to check for
differences between samples or strata, which did not
yield any significant differences. Second, the informa-
tion was provided by the responsible physician in each
case, who may have underestimated the number or
seriousness of problems.
In two other Dutch studies of the clinical aspects
of euthanasia and physician-assisted suicide, general
practitioners and nursing home physicians reported
problems in 12 percent and 7 percent of cases, respec-
tively.
 
14,15
 
 In a study of physician-assisted suicide in
the United States, Emanuel et al. reported that assist-
ed suicide failed in 3 of 20 cases described by Amer-
ican oncologists.
 
16
 
 In a study in Washington State,
no unsuccessful attempts at physician-assisted suicide
were reported.
 
17
 
 In 15 cases of physician-assisted sui-
cide in Oregon, no complications, such as vomiting
or seizures, occurred.
 
18
 
Information on problems with the performance of
euthanasia or physician-assisted suicide is relevant to
the debate about whether to legalize these practices,
for several reasons. First, such information may be
helpful in cases in which the distinction between phy-
sician-assisted suicide and euthanasia is unclear. We
found that in most cases in which assistance with sui-
cide had been intended, the physician’s role was con-
fined to prescribing or supplying the drugs to be used.
In 21 percent of the cases, however, the physician or
another person helped the patient take one or more
of the drugs. It is not clear at what point a physi-
cian’s assistance with suicide becomes euthanasia. For
example, how should cases be classified in which the
physician pours an oral medication into the patient’s
mouth because the patient is unable to administer it?
A judicial distinction between physician-assisted sui-
cide and euthanasia may be complicated by such prac-
tical issues.
 
21
 
Second, if physician-assisted suicide is legalized but
euthanasia is not, some competent patients may not
be able to end their own lives for purely physical rea-
sons, as in the case of patients with neurologic ill-
nesses who have problems with swallowing or using
their hands and patients who are physically too weak
to take all the oral medication themselves. One study
 
*In one case, intravenous injection was difficult because of lymphedema.
In two other cases, the physician finally administered the drug intramus-
cularly.
†Fluid injected into a vein flowed back out of the vein at the injection site.
‡Other problems included inappropriate equipment and drugs that were
unpleasant to swallow or that irritated the throat.
§In six cases, two complications were reported.
¶In one case, the patient’s eyes remained open, and in another case, the
patient sat up. Other complications included tachycardia, excessive produc-
tion of mucus, hiccups, perspiration, and extreme gasping.
¿Other complications were a feeling of drunkenness in one case and ex-
treme gasping in three cases.
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 SPECIFIC TECHNICAL PROBLEMS, COMPLICATIONS, 
AND PROBLEMS WITH COMPLETION.
SPECIFIC PROBLEM
EUTHANASIA
INTENDED
(N=535)
ASSISTED SUICIDE
INTENDED
(N=114)
no. of cases
Technical problems
Difficulty finding vein in which to 
inject drug
10* 1†
Problem with the intravenous catheter 4 0
Difficulty administering oral drug 4 7
Other‡ 3 3
Not specified 3 0
Complications§
Spasm or myoclonus 6 1
Cyanosis 4 1
Nausea or vomiting 2 4
Other 7¶ 4¿
Not specified 1 0
Problems with completion
Time to death was longer than ex-
pected or patient did not become 
comatose
23 14
Patient awoke from coma 5 2
*Data on the actual interval between the administration of the first drug
and death were not available for 33 cases in which euthanasia was intended
and for 9 in which assisted suicide was intended.
†In 10 cases, the interval differed from the expected interval but was not
specified as shorter or longer; in 7 cases, the physician’s assessment of the
interval was not available.
‡In five cases, the interval differed from the expected interval but was
not specified as shorter or longer; in seven cases, the physician’s assessment
of the interval was not available.
TABLE 5. INTERVAL FROM THE ADMINISTRATION OF THE FIRST 
DRUG TO DEATH AND THE PHYSICIAN’S ASSESSMENT 
OF THE INTERVAL.
PHYSICIAN’S ASSESSMENT NO. OF CASES (%) INTERVAL*
MEDIAN RANGE
min
Euthanasia intended†
All cases 535 10 0.5 min–7 days
As expected 449 (84) 10 0.5 min–4 days
Shorter than expected 18 (3) 5 0.5 min–12 hr
Longer than expected 51 (10) 180 5 min–7 days
Physician-assisted 
suicide intended‡
All cases 114 30 1 min–14 days
As expected 67 (59) 30 2 min–14 days
Shorter than expected 13 (11) 8 1 min–2 hr
Longer than expected 22 (19) 180 45 min–7 days
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found that general practitioners and nursing home
physicians preferred euthanasia to assisted suicide be-
cause of limitations imposed by the patient’s condi-
tion in 48 percent of 155 cases of euthanasia and in
78 percent of 50 cases, respectively.22
Third, a physician who decides to assist with a pa-
tient’s death should have adequate knowledge of the
technical performance of euthanasia and physician-
assisted suicide. In the Netherlands, one of the require-
ments for prudent practice concerns care in choos-
ing doses and administering medications.23 The Royal
Dutch Association of Pharmacy recognized in the
1980s that physicians and pharmacists should have at
their disposal reliable information on the technical
performance of euthanasia, and the association reg-
ularly updates its guidelines on the use and prepara-
tion of relevant drugs.12,13 Studies in the United States
and in the Netherlands have shown that many phy-
sicians lack knowledge about the use of lethal drugs
and that recommendations about which drugs to use
are not always followed.2,13,16-18,24,25
Finally, the responsible physician’s presence must
be considered. According to the Royal Dutch Med-
ical Association, the physician should be present when
euthanasia or physician-assisted suicide is carried out.
A physician who decides not to be present (e.g., at
the patient’s request) should make arrangements to
be available if the prescribed drugs fail to have the
intended effect.26 About two thirds of both general
practitioners and nursing home physicians in the
Netherlands endorse the statement that a physician
who provides assistance with suicide should be pre-
pared to administer a lethal drug if the suicide at-
tempt fails.27 To be available under such circumstanc-
es, the physician must have previously informed the
patient and the patient’s relatives about what to ex-
pect during the actual performance of physician-assist-
ed suicide, including possible complications and the
expected interval between the administration of the
medication and death.
Decisions about physician-assisted suicide and eu-
thanasia are difficult and emotional for all persons
involved. Unexpected events can be traumatic. Pro-
fessional training, empirical research, and an open
debate on the practical aspects of physician-assisted
suicide and euthanasia may contribute to the preven-
tion of complications and other clinical problems.
Supported by a grant from the Dutch Ministry of Health, Welfare, and
Sports and the Dutch Ministry of Justice.
We are indebted to Johannes J.M. van Delden and Loes Pijnen-
borg, for their contributions to the 1990–1991 study; to Ilinka
Haverkate and Jacqueline M. Cuperus-Bosma, for their contribu-
tions to the 1995–1996 study; to Caspar W.N. Looman, for his sta-
tistical advice; to all the physicians who participated in the two stud-
ies; and to the interviewers.
REFERENCES
1. van der Maas PJ, van der Wal G, Haverkate I, et al. Euthanasia, physi-
cian-assisted suicide, and other medical practices involving the end of life 
in the Netherlands, 1990–1995. N Engl J Med 1996;335:1699-705.
2. Meier DE, Emmons C-A, Wallenstein S, Quill T, Morrison RS, Cassel 
CK. A national survey of physician-assisted suicide and euthanasia in the 
United States. N Engl J Med 1998;338:1193-201.
3. Kuhse H, Singer P, Baume P, Clark M, Rickard M. End-of-life decisions 
in Australian medical practice. Med J Aust 1997;166:191-6.
4. Matzo ML, Emanuel EJ. Oncology nurses’ practices of assisted suicide 
and patient-requested euthanasia. Oncol Nurs Forum 1997;24:1725-32.
5. Emanuel EJ, Fairclough DL, Daniels ER, Clarridge BR. Euthanasia and 
physician-assisted suicide: attitudes and experiences of oncology patients, 
oncologists, and the public. Lancet 1996;347:1805-10.
6. Asch DA. The role of critical care nurses in euthanasia and assisted sui-
cide. N Engl J Med 1996;334:1374-9.
7. Doukas DJ, Waterhouse D, Gorenflo DW, Seid J. Attitudes and behav-
iors on physician-assisted death: a study of Michigan oncologists. J Clin 
Oncol 1995;13:1055-61.
8. Baume P, O’Malley E. Euthanasia: attitudes and practices of medical 
practitioners. Med J Aust 1994;161:137, 140, 142-4.
9. Fried TR, Stein MD, O’Sullivan PS, Brock DW, Novack DH. Limits of 
patient autonomy: physician attitudes and practices regarding life-sustain-
ing treatments and euthanasia. Arch Intern Med 1993;153:722-8.
10. Oreg. Rev. Stat. 127,800–127,897 (the Oregon Death with Dignity 
Act) (1994).
11. Gevers S. Euthanasia: law and practice in the Netherlands. Br Med Bull 
1996;52:326-33.
12. Toepassing en bereiding van euthanatica. ’s-Gravenhage, the Nether-
lands: Koninklijke Nederlandse Maatschappij ter bevordering der Pharma-
cie, 1994.
13. Wetenschappelijk Instituut Nederlandse Apothekers. Euthanaticarap-
port herzien. Adviezen voor de toepassing van euthanatica. Med Contact 
1998;53:1366-7.
14. van der Wal G, van Eijk JTM, Leenen HJJ, Spreeuwenberg C. Het 
gebruik van middelen bij euthanasie en hulp bij zelfdoding in de 
huisartspraktijk. Ned Tijdschr Geneeskd 1992;136:1299-305.
15. Muller MT, Hertogh CMPM, van der Wal G, Ribbe MW. Medisch-
technische aspecten van euthanasie en hulp bij zelfdoding in de verpleeg-
huisgeneeskunde. Vox Hosp 1992;16:3-7.
16. Emanuel EJ, Daniels ER, Fairclough DL, Clarridge BR. The practice 
of euthanasia and physician-assisted suicide in the United States: adher-
ence to proposed safeguards and effects on physicians. JAMA 1998;280:
507-13.
17. Back AL, Wallace JI, Starks HE, Pearlman RA. Physician-assisted sui-
cide and euthanasia in Washington State: patient requests and physician re-
sponses. JAMA 1996;275:919-25.
18. Chin AE, Hedberg K, Higginson GK, Fleming DW. Legalized physi-
cian-assisted suicide in Oregon — the first year’s experience. N Engl J Med 
1999;340:577-83.
19. Van Der Maas PJ, Van Delden JJM, Pijnenborg L, Looman CWN. Eu-
thanasia and other medical decisions concerning the end of life. Lancet 
1991;338:669-74.
20. van der Wal G, van der Maas PJ, Bosma JM, et al. Evaluation of the 
notification procedure for physician-assisted death in the Netherlands. 
N Engl J Med 1996;335:1706-11.
21. Woolfrey J. What happens now? Oregon and physician-assisted suicide. 
Hastings Cent Rep 1998;28(3):9-17.
22. Onwuteaka-Philipsen BD, Muller MT, van der Wal G, van Eijk JT, 
Ribbe MW. Active voluntary euthanasia or physician-assisted suicide? J Am 
Geriatr Soc 1997;45:1208-13.
23. Legemaate J. Legal aspects of euthanasia and assisted suicide in the 
Netherlands, 1973-1994. Camb Q Healthcare Ethics 1995;4:112-21.
24. Drickamer MA, Lee MA, Ganzini L. Practical issues in physician-
assisted suicide. Ann Intern Med 1997;126:146-51.
25. Lee MA, Nelson HD, Tilden VP, Ganzini L, Schmidt TA, Tolle SW. 
Legalizing assisted suicide — views of physicians in Oregon. N Engl J Med 
1996;334:310-5.
26. General Board RDMA. Vision on euthanasia. In: Euthanasia in the 
Netherlands. Utrecht, the Netherlands: Royal Dutch Medical Association, 
1996.
27. Onwuteaka-Philipsen BD, Muller MT, van der Wal G, van Eijk JT, 
Ribbe MW. Attitudes of Dutch general practitioners and nursing home 
physicians to active voluntary euthanasia and physician-assisted suicide. 
Arch Fam Med 1995;4:951-5.
Copyright © 2000 Massachusetts Medical Society. All rights reserved. 
Downloaded from www.nejm.org at ERASMUS UNIVERSITEIT MEDISCH BIBLIO on December 4, 2006 . 
